Clinical Trials in Mangalore

Every study on the ClinicalTrials.gov registry that lists a site in India and is open, about to open, active-but-closed, or enrolling by invitation. Filter it, cite it, and take it away as a file.

Download CSV

Source: ClinicalTrials.gov, U.S. National Library of Medicine. Complete coverage — all 1123 matching records held by the registry are in this view. Synced 21 Sep 2026, 03:16 UTC

1123

Studies in scope

all four open statuses

610

Recruiting now

open to new participants

222

Lead sponsors

across recruiting studies

Top sites

New Delhi 332 Mumbai 259 Hyderabad 237 Bangalore 193 Pune 189

Status

Study

Lead sponsor

Phase

Enrol

Indian sites

Start

Active, closed

Long-term Safety, Tolerability and Effectiveness Study of Ofatumumab in Patients With Relapsing MS

NCT03650114Relapsing Multiple Sclerosis

Novartis Pharmaceuticals

Phase 3

1,882

Mangalore, Kochi, Mumbai, Pune, New Delhi, Chandigarh, Hyderabad, Howrah

2018-12-28

Active, closed

A Study of Galcanezumab (LY2951742) in Participants 6 to 17 Years of Age With Episodic Migraine

NCT03432286Episodic Migraine

Eli Lilly and Company

Phase 3

533

Mangalore, Nagpur, New Delhi, Pune

2018-03-14

Cite this view

Priya Life Science (2026). Clinical trial register: studies with an Indian investigative site, filtered. Derived from ClinicalTrials.gov. Retrieved 21 September 2026. https://priyalifescience.com/clinical-trials-india/city/mangalore

Query this register directly

GET /api/trials?country=in&status=recruiting&format=json Try it now →

Listing here is informational and not medical advice; eligibility is determined by each study team. See also the Ireland, UK, EU, USA and China registers.